X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2976) 2976
Magazine Article (21) 21
Newsletter (11) 11
Newspaper Article (5) 5
Conference Proceeding (2) 2
Publication (2) 2
Book Review (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (2572) 2572
hypertension - drug therapy (1799) 1799
male (1763) 1763
female (1720) 1720
middle aged (1614) 1614
hydrochlorothiazide - adverse effects (1279) 1279
hydrochlorothiazide (1268) 1268
aged (1256) 1256
hydrochlorothiazide - therapeutic use (1244) 1244
hypertension (1025) 1025
adult (1017) 1017
blood pressure - drug effects (952) 952
drug therapy, combination (939) 939
antihypertensive agents - therapeutic use (773) 773
hydrochlorothiazide - administration & dosage (716) 716
antihypertensive agents - adverse effects (658) 658
double-blind method (622) 622
diuretics (580) 580
pharmacology & pharmacy (534) 534
hypertension - physiopathology (516) 516
treatment outcome (490) 490
antihypertensive agents - administration & dosage (439) 439
drug combinations (422) 422
peripheral vascular disease (422) 422
blood-pressure (384) 384
blood pressure (346) 346
diuretics - therapeutic use (315) 315
clinical trials as topic (306) 306
medicine, general & internal (296) 296
diuretics - adverse effects (288) 288
drug therapy (279) 279
tetrazoles - therapeutic use (242) 242
dose-response relationship, drug (235) 235
therapy (235) 235
amlodipine (234) 234
time factors (232) 232
aged, 80 and over (224) 224
double-blind (216) 216
cardiac & cardiovascular systems (212) 212
valsartan (212) 212
tetrazoles - adverse effects (211) 211
hypertension - complications (209) 209
risk factors (206) 206
prospective studies (204) 204
hydrochlorothiazide - pharmacology (201) 201
combination therapy (193) 193
efficacy (193) 193
risk (190) 190
heart rate - drug effects (182) 182
adolescent (181) 181
angiotensin-converting enzyme inhibitors - therapeutic use (180) 180
potassium - blood (179) 179
medicine & public health (175) 175
internal medicine (174) 174
hypertension - blood (171) 171
losartan (169) 169
angiotensin ii type 1 receptor blockers - therapeutic use (167) 167
tetrazoles - administration & dosage (166) 166
management (161) 161
mortality (159) 159
dosage and administration (158) 158
prevention (158) 158
random allocation (155) 155
sodium chloride symporter inhibitors - adverse effects (149) 149
research (146) 146
amlodipine - therapeutic use (145) 145
sodium chloride symporter inhibitors - therapeutic use (145) 145
calcium channel blockers - therapeutic use (144) 144
antihypertensive agents - pharmacology (141) 141
diuretics - administration & dosage (140) 140
antihypertensive drugs (131) 131
combination (128) 128
angiotensin-converting enzyme inhibitors - adverse effects (126) 126
health aspects (122) 122
amlodipine - adverse effects (121) 121
hypokalemia - chemically induced (121) 121
valine - analogs & derivatives (121) 121
angiotensin ii type 1 receptor blockers - adverse effects (119) 119
care and treatment (119) 119
animals (118) 118
enalapril (118) 118
follow-up studies (118) 118
amlodipine - administration & dosage (116) 116
pharmacology/toxicology (115) 115
tolerability (112) 112
angiotensin-converting enzyme inhibitors - administration & dosage (108) 108
randomized controlled trials as topic (107) 107
benzimidazoles - therapeutic use (106) 106
potassium (105) 105
safety (105) 105
amiloride - adverse effects (104) 104
antihypertensive therapy (100) 100
enalapril - therapeutic use (100) 100
trial (100) 100
disease (99) 99
imidazoles - therapeutic use (99) 99
analysis (98) 98
chlorthalidone (98) 98
diabetes (96) 96
antihypertensive efficacy (95) 95
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2757) 2757
German (95) 95
Russian (39) 39
Spanish (34) 34
French (33) 33
Italian (25) 25
Japanese (13) 13
Portuguese (9) 9
Norwegian (8) 8
Polish (7) 7
Chinese (6) 6
Czech (6) 6
Danish (6) 6
Dutch (3) 3
Swedish (3) 3
Finnish (2) 2
Hebrew (2) 2
Hungarian (2) 2
Afrikaans (1) 1
Bulgarian (1) 1
Croatian (1) 1
Korean (1) 1
Slovak (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


08/2000, Volume 23, Issue 2, 22
Various drugs are associated with adverse respiratory disorders (ARDs) ranging in severity from mild, moderate to severe and even fatal... 
Flecainide, adverse reactions | Penicillamine, adverse reactions | Antibacterials, adverse reactions | Beta blockers, adverse reactions | Leukotriene antagonists, adverse reactions | Calcium antagonists, adverse reactions | Aspirin, adverse reactions | Bromocriptine, adverse reactions | Anorectics, adverse reactions | Hydrochlorothiazide, adverse reactions | Methysergide, adverse reactions | Dextropropoxyphene, adverse reactions | Cocaine, adverse reactions | Sodium cromoglycate, adverse reactions | Gold, adverse reactions | Hormonal replacements, adverse reactions | Antiarrhythmics, adverse reactions | Nitrofurantoin, adverse reactions | Antineoplastics, adverse reactions | Opioid agonists, adverse reactions | Dipyridamole, adverse reactions | Ipratropium bromide, adverse reactions | Oral contraceptives, adverse reactions | Tocainide, adverse reactions | Methadone, adverse reactions | ACE inhibitors, adverse reactions | Diamorphine, adverse reactions | Antiasthmatics, adverse reactions | Methylphenidate, adverse reactions | Antipsychotics, adverse reactions | Corticosteroids, adverse reactions | Tocolytics, adverse reactions | Antiinflammatories, adverse reactions | Respiratory tract disorders, drug-induced | Amiodarone, adverse reactions | Medicine & Public Health | Drug Safety and Pharmacovigilance | Pharmacology/Toxicology | CHURG-STRAUSS-SYNDROME | AMIODARONE PULMONARY TOXICITY | AMPHOTERICIN-B | ASPIRIN-SENSITIVE ASTHMATICS | CONVERTING-ENZYME-INHIBITORS | INHALED SODIUM CROMOGLYCATE | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | EXERCISE-INDUCED BRONCHOCONSTRICTION | INHIBITOR-INDUCED COUGH | DOUBLE-BLIND | PHARMACOLOGY & PHARMACY | TOXICOLOGY | CHRONIC CHILDHOOD ASTHMA | Anti-Asthmatic Agents - adverse effects | Psychotropic Drugs - adverse effects | Anti-Infective Agents - adverse effects | Anti-Inflammatory Agents - adverse effects | Respiration Disorders - chemically induced | Antineoplastic Agents - adverse effects | Humans | Cardiovascular Agents - adverse effects | Respiration Disorders - therapy | Narcotics - adverse effects | Respiration Disorders - prevention & control | Incidence
Book Review
The Lancet (British edition), ISSN 0140-6736, 2010, Volume 375, Issue 9721, pp. 1173 - 1181
.... We assessed the effects of these drug combinations on progression of chronic kidney disease... 
Internal Medicine | AMLODIPINE | MORTALITY | BENAZEPRIL | MEDICINE, GENERAL & INTERNAL | CONVERTING-ENZYME-INHIBITOR | ALBUMINURIA | DISEASE | NITRIC-OXIDE | DIABETIC-NEPHROPATHY | PROGRESSION | Blood Pressure | Calcium Channel Blockers - adverse effects | Benzazepines - adverse effects | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Antihypertensive Agents - administration & dosage | Hypertension - drug therapy | Kidney Failure, Chronic - urine | Male | Albuminuria | Angiotensin-Converting Enzyme Inhibitors - adverse effects | Cardiovascular Diseases - mortality | Female | Amlodipine - administration & dosage | Hydrochlorothiazide - adverse effects | Kidney Failure, Chronic - physiopathology | Diuretics - administration & dosage | Glomerular Filtration Rate | Double-Blind Method | Risk Factors | Amlodipine - adverse effects | Hydrochlorothiazide - administration & dosage | Angiotensin-Converting Enzyme Inhibitors - administration & dosage | Disease Progression | Hypertension - physiopathology | Antihypertensive Agents - adverse effects | Calcium Channel Blockers - administration & dosage | Kidney Failure, Chronic - complications | Creatinine - blood | Hypertension - complications | Aged | Benzazepines - administration & dosage | Diuretics - adverse effects | Drug Combinations | Hypertension | Chronic kidney failure | Patient outcomes | Development and progression | Drug therapy, Combination | Drug therapy | Methods | Risk factors | Studies | Heart failure | Blister packs | Mortality | Kidney diseases | Diabetes | Drugs | blood pressure | Side effects | Filtration | secondary analysis | Dialysis | clinical trials | hypertension | Kidney
Journal Article
Hypertension (Dallas, Tex. 1979), ISSN 0194-911X, 02/2007, Volume 49, Issue 2, pp. 276 - 284
Thiazide diuretics, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers all cause reactive rises in plasma renin activity. We... 
Hypertension | Aliskiren | Renin inhibitor | Renin-angiotensin-aldosterone system | Combination therapy | Plasma renin activity | Ambulatory blood pressure measurement | SYSTEM | plasma renin activity | DESIGN | ANTAGONIST | MYOCARDIAL-INFARCTION | aliskiren | TISSUE | ambulatory blood pressure measurement | SOCIETY | renin-angiotensin-aldosterone system | RISK-FACTOR | combination therapy | PERIPHERAL VASCULAR DISEASE | renin inhibitor | ESSENTIAL-HYPERTENSION | ALDOSTERONE | hypertension | Angiotensin II Type 1 Receptor Blockers - adverse effects | Angiotensin II Type 1 Receptor Blockers - therapeutic use | Humans | Middle Aged | Biphenyl Compounds - adverse effects | Amides | Hypertension - drug therapy | Male | Sodium Chloride Symporter Inhibitors - adverse effects | Sodium Chloride Symporter Inhibitors - therapeutic use | Biphenyl Compounds - therapeutic use | Hypertension - blood | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Angiotensin-Converting Enzyme Inhibitors - adverse effects | Aged, 80 and over | Adult | Female | Blood Pressure - drug effects | Ramipril - therapeutic use | Drug Therapy, Combination | Hypertension - diagnosis | Ramipril - adverse effects | Hydrochlorothiazide - adverse effects | Fumarates - therapeutic use | Fumarates - adverse effects | Antihypertensive Agents - therapeutic use | Renin - blood | Hypertension - physiopathology | Antihypertensive Agents - adverse effects | Antihypertensive Agents - blood | Fumarates - blood | Renin - antagonists & inhibitors | Tetrazoles - therapeutic use | Aged | Patient Compliance | Tetrazoles - adverse effects | Blood Pressure Monitoring, Ambulatory | Hydrochlorothiazide - therapeutic use
Journal Article
Kidney international, ISSN 0085-2538, 06/2008, Volume 73, Issue 11, pp. 1303 - 1309
...A coexistent diagnosis of hypertension and diabetes mellitus increases the risk for adverse cardiovascular and renal outcomes. This increased risk for adverse... 
albuminuria | diabetes mellitus | benazepril | hypertension | amlodipine | hydrochlorothiazide | Hypertension | Amlodipine | Benazepril | Albuminuria | Hydrochlorothiazide | Diabetes mellitus | RENAL-FUNCTION | RISK | DIABETIC-NEPHROPATHY | BLOOD-PRESSURE | GLOMERULAR-FILTRATION-RATE | MICROALBUMINURIA | DISEASE | UROLOGY & NEPHROLOGY | ESSENTIAL-HYPERTENSION | PROGRESSION | Calcium Channel Blockers - adverse effects | Diabetic Nephropathies - etiology | Benzazepines - adverse effects | Humans | Middle Aged | Calcium Channel Blockers - therapeutic use | Diabetic Nephropathies - drug therapy | Hypertension - drug therapy | Male | Hypertension - etiology | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Angiotensin-Converting Enzyme Inhibitors - adverse effects | Aged, 80 and over | Adult | Female | Angiotensin-Converting Enzyme Inhibitors - pharmacology | Blood Pressure - drug effects | Drug Therapy, Combination | Diabetes Mellitus, Type 2 - complications | Hydrochlorothiazide - adverse effects | Albuminuria - etiology | Double-Blind Method | Amlodipine - adverse effects | Treatment Outcome | Benzazepines - pharmacology | Antihypertensive Agents - therapeutic use | Amlodipine - therapeutic use | Antihypertensive Agents - adverse effects | Benzazepines - therapeutic use | Albuminuria - drug therapy | Diuretics - therapeutic use | Aged | Hydrochlorothiazide - therapeutic use | Diuretics - adverse effects | Index Medicus
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2017, Volume 389, Issue 10073, pp. 1035 - 1042
Journal Article
Hypertension (Dallas, Tex. 1979), ISSN 0194-911X, 05/2007, Volume 49, Issue 5, pp. 1047 - 1055
Current guidelines from the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure recommend first-line treatment... 
Direct renin inhibitor | Obesity | Renin-angiotensin system | Thiazide diuretic | Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure 7 | direct renin inhibitor | thiazide diuretic | EFFICACY | Joint National Committee on Prevention, Detection, Evaluation | and Treatment of High Blood Pressure 7 | PERIPHERAL VASCULAR DISEASE | renin angiotensin system | INSULIN SENSITIVITY | obesity | BLOOD-PRESSURE | VALSARTAN | Diastole | Humans | Middle Aged | Biphenyl Compounds - adverse effects | Fumarates - administration & dosage | Hypertension - drug therapy | Male | Systole | Biphenyl Compounds - therapeutic use | Hypertension - blood | Amides - adverse effects | Adult | Female | Blood Pressure - drug effects | Hydrochlorothiazide - adverse effects | Double-Blind Method | Administration, Oral | Fumarates - therapeutic use | Obesity - complications | Amlodipine - adverse effects | Treatment Outcome | Amides - therapeutic use | Fumarates - adverse effects | Antihypertensive Agents - therapeutic use | Renin - blood | Hypertension - physiopathology | Amlodipine - therapeutic use | Antihypertensive Agents - adverse effects | Renin - antagonists & inhibitors | Hypertension - complications | Tetrazoles - therapeutic use | Aged | Tetrazoles - adverse effects | Amides - administration & dosage | Hydrochlorothiazide - therapeutic use
Journal Article
Clinical therapeutics, ISSN 0149-2918, 2012, Volume 34, Issue 8, pp. 1735 - 1750
.... However, the effects of combination therapy may be diverse because of the different components... 
Internal Medicine | Medical Education | diabetes | fixed-dose combination | hypertension | noninferiority | Hypertension | Diabetes | Fixed-dose combination | Noninferiority | MANAGEMENT | ALBUMINURIA | HYDROCHLOROTHIAZIDE | AMLODIPINE | TELMISARTAN | THERAPY | HIGH-RISK | TOLERABILITY | RENAL OUTCOMES | PHARMACOLOGY & PHARMACY | VALSARTAN | Angiotensin II Type 1 Receptor Blockers - adverse effects | Prospective Studies | Calcium Channel Blockers - adverse effects | Valsartan | Benzazepines - adverse effects | Glycated Hemoglobin A - metabolism | Humans | Middle Aged | Antihypertensive Agents - administration & dosage | Hypertension - drug therapy | Male | Valine - administration & dosage | Time Factors | Tetrazoles - administration & dosage | Lipids - blood | Angiotensin-Converting Enzyme Inhibitors - adverse effects | Female | Blood Pressure - drug effects | Uric Acid - blood | Hypertension - diagnosis | Amlodipine - administration & dosage | Diabetes Mellitus, Type 2 - complications | Angiotensin II Type 1 Receptor Blockers - administration & dosage | Hydrochlorothiazide - adverse effects | Diuretics - administration & dosage | Albuminuria - etiology | Double-Blind Method | Valine - analogs & derivatives | Amlodipine - adverse effects | Treatment Outcome | Hydrochlorothiazide - administration & dosage | Biomarkers - blood | Angiotensin-Converting Enzyme Inhibitors - administration & dosage | Hypertension - physiopathology | Antihypertensive Agents - adverse effects | Blood Glucose - drug effects | Diabetes Mellitus, Type 2 - blood | Analysis of Variance | Calcium Channel Blockers - administration & dosage | Taiwan | Hypertension - complications | Aged | Benzazepines - administration & dosage | Tetrazoles - adverse effects | Valine - adverse effects | Blood Glucose - metabolism | Diuretics - adverse effects | Drug Combinations | Type 2 diabetes | Medical research | Diabetics | Medical colleges | Care and treatment | Complications and side effects | Amlodipine | Diuretics | Medicine, Experimental | Benazepril | Dosage and administration | Drug therapy, Combination | Comparative analysis | Studies | Body mass index | Heart attacks | Disease | Mortality | Blood pressure | Kidney diseases | Regression analysis | Drug dosages
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2008, Volume 359, Issue 23, pp. 2417 - 2428
Journal Article